Fardel O, Payen L, Sparfel L, Vernhet L, Lecureur V
INSERM U456, Faculté de Pharmacie, 2 avenue du Pr. L. Bernard, F 35043 Rennes, France.
Ann Pharm Fr. 2002 Nov;60(6):380-5.
Membrane transport proteins play a major role in hepato-biliary secretion of xenobiotics. Some of them, especially OATPs and OCT1, are present at the vascular pole of hepatocytes and mediate uptake of xenobiotics into parenchymal liver cells from blood whereas others, such as P-glycoprotein and MRP2, are ABC transporters present at the canalicular domain of hepatocytes and responsible for the transmembrane passage into bile of drugs or their metabolites. Many endogenous or exogenous factors, including drug metabolizing enzyme inducers, alter expression of hepatic transporters whose activity can moreover be inhibited by various structurally-unrelated compounds. Such changes of expression and/or activity of membrane transport proteins may contribute to some drug interactions.
膜转运蛋白在肝脏对外源化学物质的胆汁分泌中起主要作用。其中一些蛋白,特别是有机阴离子转运多肽(OATPs)和有机阳离子转运体1(OCT1),存在于肝细胞的血管极,介导外源化学物质从血液摄入实质肝细胞,而其他蛋白,如P-糖蛋白和多药耐药相关蛋白2(MRP2),是存在于肝细胞胆小管域的ATP结合盒(ABC)转运体,负责药物或其代谢产物跨膜进入胆汁。许多内源性或外源性因素,包括药物代谢酶诱导剂,可改变肝转运蛋白的表达,而且其活性可被各种结构无关的化合物抑制。膜转运蛋白表达和/或活性的这种变化可能导致一些药物相互作用。